[{"NetIncomeLoss_1_Q2_USD":-166615000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":4048000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":50393000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":93787000.0,"DepreciationAndAmortization_2_Q2_USD":6056000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":278700000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-84000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-176000.0,"MarketableSecuritiesCurrent_0_Q2_USD":34410000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":56976000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":52323000.0,"EquityMethodInvestments_0_Q2_USD":162956000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":10.25,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q2_shares":2160990.0,"GainLossOnInvestments_2_Q2_USD":30530000.0,"Liabilities_0_Q2_USD":593389000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1356853000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":48387000.0,"IncreaseDecreaseInReceivables_2_Q2_USD":1429000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-176000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-84000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":10285000.0,"TreasuryStockValue_0_Q2_USD":49464000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":12524000.0,"LossContingencyLossInPeriod_2_Q2_USD":100000.0,"TreasuryStockShares_0_Q2_shares":7568182.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":-300000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":1900000.0,"LongTermDebtCurrent_0_Q2_USD":29845000.0,"OperatingLeaseExpense_1_Q2_USD":2508000.0,"OperatingLeaseExpense_2_Q2_USD":5015000.0,"AssetsCurrent_0_Q2_USD":155262000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":10418000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":2187485.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":76656000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":84623000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":1133000.0,"InterestPaidNet_2_Q2_USD":88000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":25267000.0,"PaidInKindInterest_2_Q2_USD":4010000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":77291000.0,"OtherAssetsNoncurrent_0_Q2_USD":2049000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":2936000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-165927000.0,"AccountsReceivableNetCurrent_0_Q2_USD":22437000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-584000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-6695000.0,"PrepaidExpenseCurrent_0_Q2_USD":11656000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":290003000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":285330000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_2_Q2_shares":2375892.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":328000.0,"AdjustmentForAmortization_1_Q2_USD":1070000.0,"AdjustmentForAmortization_2_Q2_USD":2105000.0,"MinorityInterest_0_Q2_USD":-633000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":4140000.0,"EarningsPerShareBasic_2_Q2_USD":-0.58,"EarningsPerShareBasic_1_Q2_USD":-0.57,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":17435000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":83172000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":5.58,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5072000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":776000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-847000.0,"CommonStockSharesIssued_0_Q2_shares":297974503.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-641000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-163492000.0,"OtherAssetsCurrent_0_Q2_USD":6784000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":95171000.0,"NonoperatingGainsLosses_1_Q2_USD":34000.0,"NonoperatingGainsLosses_2_Q2_USD":-44000.0,"CostsAndExpenses_1_Q2_USD":114061000.0,"CostsAndExpenses_2_Q2_USD":213221000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":70415000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":54506000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":98339000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-2503000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.005,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.004,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":-1000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-541000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_2_Q2_USD":10.12,"GoodwillPeriodIncreaseDecrease_2_Q2_USD":9300000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q2_USD":20984000.0,"CommonStockValue_0_Q2_USD":30000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q2_USD":10.02,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-166011000.0,"Assets_0_Q2_USD":778924000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":37769000.0,"InterestExpense_2_Q2_USD":4382000.0,"AccountsPayableCurrent_0_Q2_USD":33969000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":20499000.0,"LiabilitiesCurrent_0_Q2_USD":180452000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":10054000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":65682000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":290003000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":285330000.0,"InterestExpense_1_Q2_USD":2016000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-126572000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":688000.0,"ProceedsFromShortTermDebt_2_Q2_USD":22456000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-167340000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-165128000.0,"Goodwill_0_Q2_USD":52892000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q2_USD":3410000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":688000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":613000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":613000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":77291000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":11974000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-916000.0,"NetIncomeLoss_2_Q2_USD":-164105000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":45991000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":121504000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":808000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":6002000.0,"OperatingLeasePayments_1_Q2_USD":2567000.0,"OperatingLeasePayments_2_Q2_USD":5054000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":43345000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":536119.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":185535000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":77291000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-166615000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-164105000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.122,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":322005000.0,"LongTermDebtNoncurrent_0_Q2_USD":82574000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":3870000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-22000.0,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-441000.0,"MarketableSecuritiesGainLoss_1_Q2_USD":-63901000.0,"PreferredStockSharesAuthorized_0_Q2_shares":100000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":19112000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":778924000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":3.91,"PreferredStockValue_0_Q2_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":339440000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":10.45,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":2641000.0,"InventoryNet_0_Q2_USD":2684000.0,"OperatingIncomeLoss_1_Q2_USD":-100550000.0,"OperatingIncomeLoss_2_Q2_USD":-185455000.0,"CommonStockSharesAuthorized_0_Q2_shares":750000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2022000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":9757000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":30849000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"StockIssuedDuringPeriodValueAcquisitions_1_Q2_USD":5378000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.63,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2_Q2_shares":82362.0,"ShareBasedCompensation_2_Q2_USD":46406000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":798272.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3936000.0,"MarketableSecuritiesGainLoss_2_Q2_USD":30530000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":3845000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.58,"EarningsPerShareDiluted_1_Q2_USD":-0.57,"CommonStockSharesOutstanding_0_Q2_shares":297974503.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1122384000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":19616014.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":27766000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":13511000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":5487000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":119209000.0,"StockholdersEquity_0_Q2_USD":186168000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":1761000.0,"ProfitLoss_2_Q2_USD":-164281000.0,"ProfitLoss_1_Q2_USD":-166699000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":173000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":173000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":5739000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":2070000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":33500000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-163668000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20210806"}]